Cowen Inc. (NASDAQ: COWN) (“Cowen” or “the Company”) today
announced its operating results for the third quarter ended
September 30, 2020.
Jeffrey M. Solomon, Chair and Chief Executive
Officer of Cowen, said, "Our results for the third quarter
demonstrate the strength and sustainability of our operating
business. It was the second-best quarter on record for markets and
investment banking, we set a new record for M&A revenues and
management fees are at multi-year highs. We also took advantage of
the opportunity to repurchase shares at attractive valuations, with
the largest quarterly buyback in five years. We continue to embrace
our core values of vision, empathy, sustainability and tenacious
teamwork as we help our clients, our colleagues and our communities
to tackle their biggest challenges and navigate through these
uncertain times."
Third Quarter 2020 Financial
Summary
|
US GAAP |
|
Economic Operating Income |
|
Three Months Ended September
30, |
|
Three Months Ended September
30, |
($ in millions, except per share information) |
2020 |
|
2019 |
|
Δ % |
|
2020 |
|
2019 |
|
Δ % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue |
$ |
387.7 |
|
$ |
252.0 |
|
54 |
% |
|
$ |
274.3 |
|
|
$ |
216.5 |
|
|
27 |
% |
Net income (loss) attributable to common stockholders |
$ |
18.6 |
|
$ |
2.1 |
|
786 |
% |
|
$ |
37.4 |
|
|
$ |
10.1 |
|
|
270 |
% |
Earnings (loss) per common share (diluted) |
$ |
0.62 |
|
$ |
0.07 |
|
786 |
% |
|
$ |
1.25 |
|
|
$ |
0.32 |
|
|
291 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
Note: Throughout this press release the Company presents non-GAAP
financial measures that are not prepared in accordance with
accounting principles generally accepted in the United States of
America ("US GAAP"). A reconciliation of these non-GAAP measures
appears under the section, "Reconciliation of US GAAP (Unaudited)
to Economic Operating Income (Loss)." |
Third Quarter 2020 Operating Financial
Highlights (US GAAP) (unaudited)
Third quarter 2020 US GAAP revenue was $387.7
million compared to $252.0 million in the third quarter of
2019.
Third quarter 2020 US GAAP employee compensation
and benefits expenses was $153.4 million, an increase of $33.1
million from the prior-year period.
Third quarter 2020 US GAAP income tax expense was
$8.8 million compared to $1.4 million in the prior-year
quarter.
Third quarter 2020 US GAAP total expenses totaled
$249.2 million, an increase of $29.3 million from the prior-year
period.
Third quarter 2020 US GAAP net income attributable
to common stockholders was $18.6 million compared to net income
attributable to common stockholders of $2.1 million in the third
quarter of 2019.
Third Quarter 2020 Operating Financial
Highlights (Non-GAAP)
• |
Strong Investment Banking
performance: |
|
|
– |
Second-strongest quarter on record driven by capital markets
activity in biotech and healthcare tools & diagnostics |
|
|
– |
Record M&A revenues driven by several high-fee engagements.
Deal pipeline now at record high level |
• |
Markets revenues near record levels,
continuing share gains: |
|
|
– |
Markets revenue, which includes brokerage, financing and other
revenue, was $167.4 million ($2.62 million/day), just below the
record highs of 2Q'20 |
|
|
– |
Posted strong performances in prime services, outsourced
trading, securities finance, special situations and non-US
execution |
• |
Strong momentum in investment
management: |
|
|
– |
Management fee run-rate at highest annual level since 2016, AUM
increased year-over-year |
• |
Invested capital: Nikola position creates
quarterly volatility |
|
|
– |
Mark-to-market unrealized loss of $96.6 million on Nikola
investment partially offset by gains in balance sheet investments
including Cowen Healthcare Investments and SPAC trading |
Capital Optimization Update
As of September 30, 2020, Cowen had book
value of $30.48 per common share and tangible book value per common
share of $24.32, up from book value of $28.96 and tangible book
value of $22.94 at June 30, 2020, and up from book value of $24.77
and tangible book value of $18.72 at December 31, 2019.
In the third quarter of 2020, the Company
repurchased $18.9 million of its common stock, or 1,144,254 shares,
at an average price of $16.49 under the Company's existing share
repurchase program, representing the largest quarterly share
repurchase since the third quarter of 2015.
Outside the share repurchase program, in the third
quarter of 2020 the Company acquired approximately $267 thousand of
shares as a result of net share settlements relating to the vesting
of equity awards, or 14,985 shares, at an average price of
$17.80.
For the first nine months of 2020, the Company
repurchased 2,974,711 shares for $43.4 million, or an average price
of $14.60 under the Company's existing share repurchase program.
Outside the share repurchase program, in the first nine months of
2020 the Company acquired approximately $6.3 million of shares as a
result of net share settlements relating to the vesting of equity
awards, or 505,702 shares at an average price of $12.45.
Increased Quarterly Cash
Dividend
The Company increased its quarterly cash dividend
payable on its common stock from $0.04 to $0.08 per common share.
On October 21, 2020, the Board of Directors declared a cash
dividend of $0.08 per common share. The dividend will be payable on
December 15, 2020, to stockholders of record on December 1,
2020.
Select Balance Sheet Data
(Amounts in millions, except per share information) |
|
|
|
|
September
30, 2020 |
|
December 31, 2019 |
Cowen Inc. stockholders' equity |
$911.2 |
|
$809.9 |
Common equity (CE) |
$809.9 |
|
$708.5 |
Tangible common equity (TCE) |
$646.1 |
|
$535.6 |
|
|
|
|
Book value per share (CE/CSO) |
$30.48 |
|
$24.77 |
Tangible book value per share (TCE/CSO) |
$24.32 |
|
$18.72 |
|
|
|
|
Common shares outstanding (CSO) |
26.6 |
|
28.6 |
|
|
|
|
Note: Common Equity (CE) is calculated as Cowen Inc, stockholders’
equity less our preferred stock issuance. Tangible common equity
(TCE) is calculated as common equity (CE) less goodwill and net
intangible assets. |
Cowen
Inc. |
US GAAP
Preliminary Unaudited Condensed Consolidated Statements of
Operations |
(Dollar and share
amounts in thousands, except per share data) |
|
|
|
|
|
|
|
|
|
Three Months
Ended |
|
Nine Months
Ended |
|
September
30, |
|
September
30, |
|
2020 |
|
2019 |
|
2020 |
|
2019 |
Revenue |
|
|
|
|
|
|
|
Investment banking |
$ |
194,341 |
|
|
$ |
77,292 |
|
$ |
503,351 |
|
|
$ |
272,103 |
Brokerage |
138,483 |
|
|
93,995 |
|
425,069 |
|
|
302,840 |
Management fees |
11,954 |
|
|
7,300 |
|
35,211 |
|
|
21,480 |
Incentive income |
127 |
|
|
701 |
|
127 |
|
|
724 |
Interest and dividends |
37,552 |
|
|
60,707 |
|
127,547 |
|
|
129,846 |
Reimbursement from affiliates |
269 |
|
|
238 |
|
777 |
|
|
780 |
Reinsurance premiums |
2,505 |
|
|
8,146 |
|
18,943 |
|
|
29,068 |
Other |
1,369 |
|
|
1,237 |
|
4,709 |
|
|
3,228 |
Consolidated Funds revenues |
1,135 |
|
|
2,431 |
|
4,650 |
|
|
8,239 |
Total revenue |
387,735 |
|
|
252,047 |
|
1,120,384 |
|
|
768,308 |
Interest and dividends expense |
37,754 |
|
|
56,477 |
|
125,850 |
|
|
125,089 |
Total net revenue |
349,981 |
|
|
195,570 |
|
994,534 |
|
|
643,219 |
Expenses |
|
|
|
|
|
|
|
Employee compensation and benefits |
153,427 |
|
|
120,320 |
|
583,137 |
|
|
388,611 |
Reinsurance claims, commissions and amortization of deferred
acquisition costs |
4,852 |
|
|
8,195 |
|
21,716 |
|
|
25,139 |
Operating, general, administrative and other expenses |
84,784 |
|
|
83,851 |
|
264,950 |
|
|
250,915 |
Depreciation and amortization expense |
5,682 |
|
|
5,082 |
|
17,324 |
|
|
14,990 |
Goodwill impairment |
— |
|
|
— |
|
— |
|
|
4,100 |
Consolidated Funds expenses |
494 |
|
|
2,516 |
|
4,793 |
|
|
6,229 |
Total expenses |
249,239 |
|
|
219,964 |
|
891,920 |
|
|
689,984 |
Other income (loss) |
|
|
|
|
|
|
|
Net (losses) gains on securities, derivatives and other
investments |
(68,781 |
) |
|
18,446 |
|
83,738 |
|
|
61,440 |
Consolidated Funds net (losses) gains |
6,385 |
|
|
13,896 |
|
(29,410 |
) |
|
21,536 |
Total other income (loss) |
(62,396 |
) |
|
32,342 |
|
54,328 |
|
|
82,976 |
|
|
|
|
|
|
|
|
Income (loss) before income taxes |
38,346 |
|
|
7,948 |
|
156,942 |
|
|
36,211 |
Income tax
expense/(benefit) |
8,830 |
|
|
1,365 |
|
52,589 |
|
|
9,615 |
Net income (loss) |
29,516 |
|
|
6,583 |
|
104,353 |
|
|
26,596 |
Net income
(loss) attributable to non-controlling interests in consolidated
subsidiaries and funds |
9,232 |
|
|
2,770 |
|
(19,843 |
) |
|
7,188 |
Net
income (loss) attributable to Cowen Inc. |
20,284 |
|
|
3,813 |
|
124,196 |
|
|
19,408 |
Less: Preferred stock dividends |
1,698 |
|
|
1,698 |
|
5,094 |
|
|
5,094 |
Net
income (loss) attributable to Cowen Inc. common
stockholders |
$ |
18,586 |
|
|
$ |
2,115 |
|
$ |
119,102 |
|
|
$ |
14,314 |
|
|
|
|
|
|
|
|
Earnings (loss) per share: |
|
|
|
|
|
|
|
Basic |
$ |
0.67 |
|
|
$ |
0.07 |
|
$ |
4.24 |
|
|
$ |
0.48 |
Diluted |
$ |
0.62 |
|
|
$ |
0.07 |
|
$ |
4.02 |
|
|
$ |
0.46 |
|
|
|
|
|
|
|
|
Weighted average shares used in per share
data: |
|
|
|
|
|
|
|
Basic |
27,663 |
|
|
29,529 |
|
28,078 |
|
|
29,687 |
Diluted |
29,970 |
|
|
31,264 |
|
29,646 |
|
|
31,381 |
Third Quarter 2020 Economic Income
Financial Review
|
Three Months Ended |
|
Nine Months Ended |
|
September 30, 2020 |
|
September 30, 2019 |
|
September 30, 2020 |
|
September 30, 2019 |
(Dollar
amounts in thousands) |
Op Co |
|
Asset Co |
|
Total |
|
Op Co |
|
Asset Co |
|
Total |
|
Op Co |
|
Asset Co |
|
Total |
|
Op Co |
|
Asset Co |
|
Total |
Investment banking |
$ |
185,151 |
|
|
$ |
— |
|
|
$ |
185,151 |
|
|
$ |
69,433 |
|
|
$ |
— |
|
|
$ |
69,433 |
|
|
$ |
474,778 |
|
|
$ |
— |
|
|
$ |
474,778 |
|
|
$ |
254,374 |
|
$ |
— |
|
|
$ |
254,374 |
Brokerage |
167,084 |
|
|
— |
|
|
167,084 |
|
|
110,178 |
|
|
— |
|
|
110,178 |
|
|
466,823 |
|
|
— |
|
|
466,823 |
|
|
346,095 |
|
— |
|
|
346,095 |
Management fees |
14,374 |
|
|
262 |
|
|
14,636 |
|
|
10,321 |
|
|
586 |
|
|
10,907 |
|
|
41,724 |
|
|
634 |
|
|
42,358 |
|
|
30,016 |
|
1,788 |
|
|
31,804 |
Incentive income |
(2,621 |
) |
|
1,319 |
|
|
(1,302 |
) |
|
15,251 |
|
|
(862 |
) |
|
14,389 |
|
|
40,829 |
|
|
158 |
|
|
40,987 |
|
|
33,998 |
|
762 |
|
|
34,760 |
Investment income (loss) |
(90,364 |
) |
|
(124 |
) |
|
(90,488 |
) |
|
10,913 |
|
|
822 |
|
|
11,735 |
|
|
32,566 |
|
|
(13,671 |
) |
|
18,895 |
|
|
13,827 |
|
5,289 |
|
|
19,116 |
Other revenue |
(796 |
) |
|
2 |
|
|
(794 |
) |
|
(132 |
) |
|
6 |
|
|
(126 |
) |
|
(298 |
) |
|
4 |
|
|
(294 |
) |
|
5,295 |
|
56 |
|
|
5,351 |
Total revenue |
272,828 |
|
|
1,459 |
|
|
274,287 |
|
|
215,964 |
|
|
552 |
|
|
216,516 |
|
|
1,056,422 |
|
|
(12,875 |
) |
|
1,043,547 |
|
|
683,605 |
|
7,895 |
|
|
691,500 |
Interest Expense |
6,026 |
|
|
1,109 |
|
|
7,135 |
|
|
5,758 |
|
|
1,389 |
|
|
7,147 |
|
|
18,471 |
|
|
4,014 |
|
|
22,485 |
|
|
16,371 |
|
4,046 |
|
|
20,417 |
Total net revenues |
266,802 |
|
|
350 |
|
|
267,152 |
|
|
210,206 |
|
|
(837 |
) |
|
209,369 |
|
|
1,037,951 |
|
|
(16,889 |
) |
|
1,021,062 |
|
|
667,234 |
|
3,849 |
|
|
671,083 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation & Benefits |
152,829 |
|
|
957 |
|
|
153,786 |
|
|
121,890 |
|
|
729 |
|
|
122,619 |
|
|
582,480 |
|
|
2,093 |
|
|
584,573 |
|
|
386,593 |
|
4,383 |
|
|
390,976 |
Fixed non-compensation expense |
34,257 |
|
|
127 |
|
|
34,384 |
|
|
36,458 |
|
|
625 |
|
|
37,083 |
|
|
106,350 |
|
|
378 |
|
|
106,728 |
|
|
107,889 |
|
2,485 |
|
|
110,374 |
Variable non-compensation expense |
37,736 |
|
|
6 |
|
|
37,742 |
|
|
37,216 |
|
|
40 |
|
|
37,256 |
|
|
121,846 |
|
|
18 |
|
|
121,864 |
|
|
113,728 |
|
127 |
|
|
113,855 |
Depreciation & Amortization |
5,670 |
|
|
5 |
|
|
5,675 |
|
|
5,073 |
|
|
9 |
|
|
5,082 |
|
|
16,756 |
|
|
17 |
|
|
16,773 |
|
|
14,957 |
|
30 |
|
|
14,987 |
Non-Controlling Interest |
2,105 |
|
|
— |
|
|
2,105 |
|
|
661 |
|
|
— |
|
|
661 |
|
|
5,584 |
|
|
— |
|
|
5,584 |
|
|
2,944 |
|
— |
|
|
2,944 |
Total expenses |
232,597 |
|
|
1,095 |
|
|
233,692 |
|
|
201,298 |
|
|
1,403 |
|
|
202,701 |
|
|
833,016 |
|
|
2,506 |
|
|
835,522 |
|
|
626,111 |
|
7,025 |
|
|
633,136 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less:
Preferred Dividend |
1,415 |
|
|
283 |
|
|
1,698 |
|
|
1,341 |
|
|
357 |
|
|
1,698 |
|
|
4,160 |
|
|
934 |
|
|
5,094 |
|
|
4,058 |
|
1,036 |
|
|
5,094 |
Economic Income (Loss) attributable to Common
Shareholders |
32,790 |
|
|
(1,028 |
) |
|
31,762 |
|
|
7,567 |
|
|
(2,597 |
) |
|
4,970 |
|
|
200,775 |
|
|
(20,329 |
) |
|
180,446 |
|
|
37,065 |
|
(4,212 |
) |
|
32,853 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Add:
Depreciation & Amortization |
5,670 |
|
|
5 |
|
|
5,675 |
|
|
5,073 |
|
|
9 |
|
|
5,082 |
|
|
16,756 |
|
|
17 |
|
|
16,773 |
|
|
14,957 |
|
30 |
|
|
14,987 |
Economic Operating Income (Loss) attributable to Common
Shareholders |
$ |
38,460 |
|
|
$ |
(1,023 |
) |
|
$ |
37,437 |
|
|
$ |
12,640 |
|
|
$ |
(2,588 |
) |
|
$ |
10,052 |
|
|
$ |
217,531 |
|
|
$ |
(20,312 |
) |
|
$ |
197,219 |
|
|
$ |
52,022 |
|
$ |
(4,182 |
) |
|
$ |
47,840 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Economic
Income per common share |
$ |
1.09 |
|
|
$ |
(0.03 |
) |
|
$ |
1.06 |
|
|
$ |
0.24 |
|
|
$ |
(0.08 |
) |
|
$ |
0.16 |
|
|
$ |
6.77 |
|
|
$ |
(0.69 |
) |
|
$ |
6.08 |
|
|
$ |
1.17 |
|
$ |
(0.13 |
) |
|
$ |
1.04 |
Economic
Operating Income per common share |
$ |
1.28 |
|
|
$ |
(0.03 |
) |
|
$ |
1.25 |
|
|
$ |
0.40 |
|
|
$ |
(0.08 |
) |
|
$ |
0.32 |
|
|
$ |
7.34 |
|
|
$ |
(0.69 |
) |
|
$ |
6.65 |
|
|
$ |
1.66 |
|
$ |
(0.13 |
) |
|
$ |
1.53 |
Economic Income total revenues were $274.3
million versus $216.5 million in the third quarter of 2019, an
increase of 27%. Op Co revenue included in economic income was
$272.8 million while Asset Co revenue included in economic income
was $1.5 million.
Investment Banking revenues were
$185.2 million, up 167% versus the prior-year period, driven by
stronger equity capital markets activity as well as higher-fee
M&A transactions.
Brokerage revenues of $167.1
million were up 52% versus the prior-year period, driven by
strength in non-US trading, electronic trading, prime services and
securities finance.
Management Fees rose 34%
year-over-year to $14.6 million in the third quarter, driven by
higher AUM in the sustainability strategy, private healthcare
strategy and the healthcare royalties strategy. Management fees in
Asset Co. were $0.3 million.
Incentive Income posted a loss of
$1.3 million in the third quarter of 2020, down from income of
$14.4 million in the prior-year period. Third quarter 2020
incentive income reflects the impact of mark-to-market declines in
the value of positions in the private healthcare strategy,
partially offset by a gain of $1.3 million in Asset Co.
Investment Income posted a loss
of $90.5 million, versus income of $11.7 million in the prior-year
period. The third quarter 2020 revenues include a $96.6 million
unrealized loss on the investment in Nikola partially offset by
positive performance in the event driven strategy, the healthcare
strategy and the activist strategy. Investment income includes
markdowns in Asset Co investments of $0.1 million.
Compensation and benefits expense
was $153.8 million compared to $122.6 million in the third quarter
of 2019. The increase was due to higher revenues offset only
partially by a lower compensation to revenue ratio, as well as a
$48.3 million reversal of a compensation accrual that was booked
through 2Q 2020 related to previous gains on the Nikola investment.
The third quarter 2020 compensation-to-revenue ratio was 56.1%, up
from 54.6% in 2Q20 and down from 56.6% in 3Q19.
Fixed non-compensation expenses
decreased $2.7 million from the prior-year period to $34.4 million.
The decrease was due in part to lower service fees and reduced
office service expenses.
Variable non-compensation
expenses were $37.7 million, up from $37.3 million in the third
quarter of 2019. The increase is related in part to higher
brokerage and trade execution costs due to increased volumes,
partially offset by lower travel, entertainment and business
development expenses.
Economic Operating Income, which
represents Economic Income attributable to common stockholders
before depreciation and amortization, was $37.4 million for the
third quarter of 2020, up from $10.1 million in the prior-year
period. Third quarter 2020 Economic Operating Income for Op Co was
$38.5 million, while Asset Co Economic Operating loss was $1.0
million.
Assets Under Management As of
September 30, 2020, the Company had assets under management of
$11.8 billion, an increase of $0.3 billion from June 30, 2020 and
an increase of $1.0 billion from September 30, 2019,
respectively.
Invested Capital As of September
30, 2020, the Company had invested capital in Op Co totaling $784.2
million, up from $711.8 million as of June 30, 2020, as an increase
in invested broker dealer capital more than offset the impact of
the mark-to-market on the Nikola investment.
As of Sept 30, 2020, the Company had invested
capital in Asset Co totaling $127.7 million, an increase of $3.3
million from the invested capital invested as of June 30, 2020.
The largest Asset Co investments were the stake in
Italian wireless broadband provider Linkem ($77.4 million), private
equity funds Formation8/Eclipse ($39.1 million) and other private
investments ($9.3 million).
Earnings Conference Call
Management will hold a conference call today,
October 27, 2020 at 9:00 am ET to discuss these results and
provide an update on business conditions.
Chair and Chief Executive Officer Jeffrey M.
Solomon and Chief Financial Officer Stephen A. Lasota will host the
presentation, followed by a question and answer period.
U.S. dial in: (855) 760-0961
International dial-in: (631) 485-4850
Passcode: 8591505
Please call the conference telephone number at
least 15 minutes prior to the start time.
The call can also be accessed through live audio
webcast via this direct link:
https://edge.media-server.com/mmc/p/nazu2fc3
A replay of the call will be available for one
week beginning at 12:00 pm ET on October 27, 2020 on the
Company’s website at investor.cowen.com/investor-calls or via
the following numbers:
U.S. replay dial-in: (855)
859-2056 International replay dial-in: (404)
537-3406 Replay ID: 8591505
About Cowen Inc. Cowen
Inc. (“Cowen” or the “Company”) is a diversified financial
services firm offering investment banking services, research, sales
and trading, prime brokerage, global clearing, commission
management services and investment management. Cowen focuses on
delivering value-added capabilities to our clients in order to help
them outperform. Founded in 1918, the Company is headquartered
in New York and has offices worldwide. Learn more
at Cowen.com
Investor Relations Contact: JT
Farley (646) 562-1056 james.farley@cowen.com Source: Cowen Inc.
Cautionary Note Regarding Forward-Looking
Statements
This press release contains forward-looking
statements. Forward-looking statements provide the Company’s
current expectations or forecasts of future events. Forward-looking
statements include statements about the Company’s expectations,
beliefs, plans, objectives, intentions, assumptions and other
statements that are not historical facts. Forward-looking
statements are subject to known and unknown risks and uncertainties
and are based on potentially inaccurate assumptions that could
cause actual results to differ materially from those expected or
implied by the forward-looking statements. As a result of the
spread of COVID-19, economic uncertainties have arisen that have
the potential in future periods to negatively impact the Company’s
business, financial condition, results of operation, cash flows,
strategies and prospects. The extent of the impact of COVID-19 on
the Company’s operational and financial performance will depend on
certain developments, including the duration and spread of the
outbreak and impact on our clients, employees, vendors and the
markets in which we operate our businesses, all of which are
uncertain and cannot be reasonably estimated at this time. The
Company’s actual results could differ materially from those
anticipated in forward-looking statements for many reasons,
including the factors described in the sections entitled “Risk
Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations” in the Company’s Annual Report
on Form 10-K and Quarterly Reports on Form 10-Q as filed with the
Securities and Exchange Commission. The Annual Report on Form 10-K
and Quarterly Reports on Form 10-Q are available at our website at
www.cowen.com and at the Securities and Exchange Commission website
at www.sec.gov. Unless required by law, the Company undertakes no
obligation to publicly update or revise any forward-looking
statement to reflect circumstances or events after the date of this
press release.
Non-GAAP Financial
Measures
In addition to the results presented above in
accordance with US GAAP, the Company presents supplemental
financial measures that are non-GAAP measures. The Company believes
that these non-GAAP measures, viewed in addition to, and not in
lieu of, the Company’s reported US GAAP results, provide useful
information to investors and analysts regarding its performance and
overall results of operations as it presents investors and analysts
with a supplemental operating view of the Company’s financials to
help better inform their analysis of the Company’s performance.
These metrics are an integral part of the Company’s internal
reporting to measure the performance of its business segments,
allocate capital and other strategic decisions as well as assess
the overall effectiveness of senior management. Reconciliations to
comparable US GAAP measures are available in the accompanying
schedules. The non-GAAP measures presented herein may not be
comparable to similarly titled measures presented by other public
companies, and are not identical to corresponding measures used in
our various agreements or public filings.
Economic Income (Loss) may not be comparable to
similarly titled measures used by other public companies. Economic
Income (Loss) should not be considered in isolation or as a
substitute for net income, operating cash flows, investing and
financing activities, or other income or cash flow statement data
prepared in accordance with US GAAP. As a result of the adjustments
made to arrive at Economic Income (Loss) described below, Economic
Income (Loss) has limitations in that it does not take into account
certain items included or excluded under US GAAP, including its
consolidated funds.
In general, Economic Income (Loss) is a pre-tax
measure that (i) includes management reclassifications which the
Company believes provides additional insight on the performance of
the Company’s core businesses and divisions (ii) eliminates the
impact of consolidation for Consolidated Funds and excludes
(iii) goodwill and intangible impairment (iv) certain other
transaction-related adjustments and/or reorganization expenses and
(v) certain costs associated with debt. Economic Operating Income
(Loss) is a similar measure but before depreciation and
amortization expenses.
Reconciliation of Net Income Attributable
to Cowen Inc. Common Stockholders to Economic Income and Economic
Operating Income
|
|
Three Months
Ended |
|
Nine Months
Ended |
|
|
September
30, |
|
September
30, |
(Dollar amounts in thousands) |
2020 |
|
2019 |
|
2020 |
|
2019 |
|
|
|
|
|
|
|
|
|
US GAAP Net income (loss) attributable to Cowen Inc. common
stockholders |
$ |
18,586 |
|
$ |
2,115 |
|
$ |
119,102 |
|
$ |
14,314 |
|
Adjustments: |
|
|
|
|
|
|
|
|
Income tax expense (benefit) |
8,693 |
|
1,287 |
|
52,247 |
|
9,567 |
|
Amortization of discount on convertible debt |
1,152 |
|
1,092 |
|
3,394 |
|
3,208 |
|
Contingent liability adjustments |
3,023 |
|
300 |
|
4,781 |
|
298 |
|
Goodwill & intangible impairment |
— |
|
— |
|
544 |
|
4,100 |
|
Transaction-related and other costs |
308 |
|
176 |
|
378 |
|
1,366 |
|
Economic Income (Loss) |
$ |
31,762 |
|
$ |
4,970 |
|
$ |
180,446 |
|
$ |
32,853 |
|
Add back: Depreciation and amortization expense |
5,675 |
|
5,082 |
|
16,773 |
|
14,987 |
|
Economic Operating Income (Loss) |
$ |
37,437 |
|
$ |
10,052 |
|
$ |
197,219 |
|
$ |
47,840 |
Earnings Per Common Share (Diluted) to Economic Income
Per Common Share (Diluted) and Economic Operating Income Per Common
Share (Diluted)
|
|
Three Months
Ended |
|
Nine Months
Ended |
|
|
September
30, |
|
September
30, |
(Dollars per share) |
2020 |
|
2019 |
|
2020 |
|
2019 |
|
|
|
|
|
|
|
|
|
Earnings (loss) per common share (diluted): |
$ |
0.62 |
|
$ |
0.07 |
|
$ |
4.02 |
|
$ |
0.46 |
|
Adjustments: |
|
|
|
|
|
|
|
|
Income tax expense (benefit) |
0.29 |
|
0.04 |
|
1.76 |
|
0.30 |
|
Amortization of discount on convertible debt |
0.04 |
|
0.03 |
|
0.11 |
|
0.10 |
|
Contingent liability adjustments |
0.10 |
|
0.01 |
|
0.16 |
|
0.01 |
|
Goodwill & intangible impairment |
— |
|
— |
|
0.02 |
|
0.13 |
|
Transaction-related and other costs |
0.01 |
|
0.01 |
|
0.01 |
|
0.04 |
|
Economic income (Loss) per common share
(diluted) |
$ |
1.06 |
|
$ |
0.16 |
|
$ |
6.08 |
|
$ |
1.04 |
|
Add back: Depreciation and amortization expense |
0.19 |
|
0.16 |
|
0.57 |
|
0.49 |
|
Economic Operating Income (Loss) per common share
(diluted) |
$ |
1.25 |
|
$ |
0.32 |
|
$ |
6.65 |
|
$ |
1.53 |
|
Three Months Ended September 30, 2020 |
|
US GAAP |
|
Reclassifications and Adjustments |
|
Economic Income |
(Dollars amounts in thousands) |
Net income (loss) |
|
Management Reclassifications |
|
Fund Consolidation Reclassifications (k) |
|
Income Statement Adjustments |
|
Total Economic Income/(Loss) |
|
Operating Company |
|
Asset Company |
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment banking |
$ |
194,341 |
|
|
$ |
(9,190 |
) |
a, b |
$ |
— |
|
|
$ |
— |
|
|
$ |
185,151 |
|
|
$ |
185,151 |
|
|
$ |
— |
|
Brokerage |
138,483 |
|
|
28,601 |
|
c, h |
— |
|
|
— |
|
|
$ |
167,084 |
|
|
167,084 |
|
|
— |
|
Management fees |
11,954 |
|
|
2,519 |
|
d, e |
163 |
|
|
— |
|
|
$ |
14,636 |
|
|
14,374 |
|
|
262 |
|
Incentive income (loss) |
127 |
|
|
(1,462 |
) |
e |
33 |
|
|
— |
|
|
$ |
(1,302 |
) |
|
(2,621 |
) |
|
1,319 |
|
Investment income (loss) |
— |
|
|
(90,488 |
) |
f |
— |
|
|
— |
|
|
$ |
(90,488 |
) |
|
(90,364 |
) |
|
(124 |
) |
Interest and dividends |
37,552 |
|
|
(37,552 |
) |
c |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Reimbursement from affiliates |
269 |
|
|
(269 |
) |
b |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Reinsurance premiums |
2,505 |
|
|
(2,505 |
) |
g |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Other revenue |
1,369 |
|
|
(2,160 |
) |
g |
(3 |
) |
|
— |
|
|
(794 |
) |
|
(796 |
) |
|
2 |
|
Consolidated Funds revenues |
1,135 |
|
|
— |
|
|
(1,135 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Total revenues |
387,735 |
|
|
(112,506 |
) |
|
(942 |
) |
|
— |
|
|
274,287 |
|
|
272,828 |
|
|
1,459 |
|
Interest expense (Economic Income/(Loss)) / Interest and dividend
expense (US GAAP) |
37,754 |
|
|
(29,467 |
) |
c |
— |
|
|
(1,152 |
) |
l |
7,135 |
|
|
6,026 |
|
|
1,109 |
|
Total net revenues |
349,981 |
|
|
(83,039 |
) |
|
(942 |
) |
|
1,152 |
|
|
267,152 |
|
|
266,802 |
|
|
350 |
|
Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation & benefits |
153,427 |
|
|
359 |
|
i |
— |
|
|
— |
|
|
153,786 |
|
|
152,829 |
|
|
957 |
|
Fixed non-compensation expense |
— |
|
|
37,708 |
|
e, j |
— |
|
|
(3,324 |
) |
m |
34,384 |
|
|
34,257 |
|
|
127 |
|
Variable non-compensation expense |
— |
|
|
37,742 |
|
j |
— |
|
|
— |
|
|
37,742 |
|
|
37,736 |
|
|
6 |
|
Other non-compensation expense |
89,636 |
|
|
(89,636 |
) |
a, b, d, g, i |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Depreciation & amortization |
5,682 |
|
|
— |
|
|
— |
|
|
(7 |
) |
n |
5,675 |
|
|
5,670 |
|
|
5 |
|
Non-controlling interest |
— |
|
|
2,105 |
|
j |
— |
|
|
— |
|
|
2,105 |
|
|
2,105 |
|
|
— |
|
Consolidated Funds expenses |
494 |
|
|
— |
|
|
(494 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Total expenses |
249,239 |
|
|
(11,722 |
) |
|
(494 |
) |
|
(3,331 |
) |
|
233,692 |
|
|
232,597 |
|
|
1,095 |
|
Other income (loss) |
(62,396 |
) |
|
64,896 |
|
e, f, h |
(2,500 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Income taxes expense / (benefit) |
8,830 |
|
|
(137 |
) |
|
— |
|
|
(8,693 |
) |
o |
— |
|
|
— |
|
|
— |
|
Income (loss) attributable to non-controlling interests in
consolidated subsidiaries and investment funds |
9,232 |
|
|
(6,284 |
) |
j |
(2,948 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Income (loss) attributable to Cowen Inc. |
20,284 |
|
|
— |
|
|
— |
|
|
13,176 |
|
|
33,460 |
|
|
34,205 |
|
|
(745 |
) |
Less: Preferred stock dividends |
1,698 |
|
|
— |
|
|
— |
|
|
— |
|
|
1,698 |
|
|
1,415 |
|
|
283 |
|
Economic Income (Loss)/ Income (loss) attributable to Cowen
Inc. common stockholders |
$ |
18,586 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
13,176 |
|
|
31,762 |
|
|
32,790 |
|
|
(1,028 |
) |
Add back: Depreciation and amortization expense |
|
|
|
|
|
|
|
|
5,675 |
|
|
5,670 |
|
|
5 |
|
Economic Operating Income (Loss) |
|
|
|
|
|
|
|
|
$ |
37,437 |
|
|
$ |
38,460 |
|
|
$ |
(1,023 |
) |
|
Three Months Ended September 30, 2019 |
|
US GAAP |
|
Reclassifications and Adjustments |
|
Economic Income |
(Dollars amounts in thousands) |
Net income (loss) |
|
Management Reclassifications |
|
Fund Consolidation Reclassifications (k) |
|
Income Statement Adjustments |
|
Total Economic Income/(Loss) |
|
Operating Company |
|
Asset Company |
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment banking |
$ |
77,292 |
|
$ |
(7,859 |
) |
a, b |
$ |
— |
|
|
$ |
— |
|
|
$ |
69,433 |
|
|
$ |
69,433 |
|
|
$ |
— |
|
Brokerage |
93,995 |
|
16,183 |
|
c, h |
— |
|
|
— |
|
|
110,178 |
|
|
110,178 |
|
|
— |
|
Management fees |
7,300 |
|
3,033 |
|
d, e |
574 |
|
|
— |
|
|
10,907 |
|
|
10,321 |
|
|
586 |
|
Incentive income (loss) |
701 |
|
13,675 |
|
e |
13 |
|
|
— |
|
|
14,389 |
|
|
15,251 |
|
|
(862 |
) |
Investment income (loss) |
— |
|
11,735 |
|
f |
— |
|
|
— |
|
|
11,735 |
|
|
10,913 |
|
|
822 |
|
Interest and dividends |
60,707 |
|
(60,707 |
) |
c |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Reimbursement from affiliates |
238 |
|
(265 |
) |
b |
27 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Reinsurance premiums |
8,146 |
|
(8,146 |
) |
g |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Other revenue |
1,237 |
|
(1,389 |
) |
g |
26 |
|
|
— |
|
|
(126 |
) |
|
(132 |
) |
|
6 |
|
Consolidated Funds revenues |
2,431 |
|
— |
|
|
(2,431 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Total revenues |
252,047 |
|
(33,740 |
) |
|
(1,791 |
) |
|
— |
|
|
216,516 |
|
|
215,964 |
|
|
552 |
|
Interest expense (Economic Income/(Loss)) / Interest and dividend
expense (US GAAP) |
56,477 |
|
(48,238 |
) |
c |
— |
|
|
(1,092 |
) |
l |
7,147 |
|
|
5,758 |
|
|
1,389 |
|
Total net revenues |
195,570 |
|
14,498 |
|
|
(1,791 |
) |
|
1,092 |
|
|
209,369 |
|
|
210,206 |
|
|
(837 |
) |
Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation & benefits |
120,320 |
|
2,299 |
|
i |
— |
|
|
— |
|
|
122,619 |
|
|
121,890 |
|
|
729 |
|
Fixed non-compensation expense |
— |
|
37,559 |
|
e, j |
— |
|
|
(476 |
) |
m |
37,083 |
|
|
36,458 |
|
|
625 |
|
Variable non-compensation expense |
— |
|
37,256 |
|
j |
— |
|
|
— |
|
|
37,256 |
|
|
37,216 |
|
|
40 |
|
Other non-compensation expense |
92,046 |
|
(92,046 |
) |
a, b, d, g, i |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Depreciation & amortization |
5,082 |
|
— |
|
|
— |
|
|
— |
|
|
5,082 |
|
|
5,073 |
|
|
9 |
|
Non-controlling interest |
— |
|
661 |
|
j |
— |
|
|
— |
|
|
661 |
|
|
661 |
|
|
— |
|
Consolidated Funds expenses |
2,516 |
|
— |
|
|
(2,516 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Total expenses |
219,964 |
|
(14,271 |
) |
|
(2,516 |
) |
|
(476 |
) |
|
202,701 |
|
|
201,298 |
|
|
1,403 |
|
Other income (loss) |
32,342 |
|
(26,721 |
) |
e, f, h |
(5,621 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Income taxes expense / (benefit) |
1,365 |
|
(78 |
) |
|
— |
|
|
(1,287 |
) |
o |
— |
|
|
— |
|
|
— |
|
Income (loss) attributable to non-controlling interests in
consolidated subsidiaries and investment funds |
2,770 |
|
2,126 |
|
j |
(4,896 |
) |
|
|
|
— |
|
|
— |
|
|
— |
|
Income (loss) attributable to Cowen Inc. |
3,813 |
|
— |
|
|
— |
|
|
2,855 |
|
|
6,668 |
|
|
8,908 |
|
|
(2,240 |
) |
Less: Preferred stock dividends |
1,698 |
|
— |
|
|
— |
|
|
— |
|
|
1,698 |
|
|
1,341 |
|
|
357 |
|
Economic Income (Loss)/ Income (loss) attributable to Cowen
Inc. common stockholders |
$ |
2,115 |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
2,855 |
|
|
4,970 |
|
|
7,567 |
|
|
(2,597 |
) |
Add back: Depreciation and amortization expense |
|
|
|
|
|
|
|
|
5,082 |
|
|
5,073 |
|
|
9 |
|
Economic Operating Income (Loss) |
|
|
|
|
|
|
|
|
$ |
10,052 |
|
|
$ |
12,640 |
|
|
$ |
(2,588 |
) |
|
Nine Months Ended September 30, 2020 |
|
US GAAP |
|
Reclassifications and Adjustments |
|
Economic Income |
(Dollars amounts in thousands) |
Net income (loss) |
|
Management Reclassifications |
|
Fund Consolidation Reclassifications (k) |
|
Income Statement Adjustments |
|
Total Economic Income/(Loss) |
|
Operating Company |
|
Asset Company |
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment banking |
$ |
503,351 |
|
|
$ |
(28,573 |
) |
a, b |
$ |
— |
|
|
$ |
— |
|
|
$ |
474,778 |
|
|
$ |
474,778 |
|
|
$ |
— |
|
Brokerage |
425,069 |
|
|
41,754 |
|
c, h |
— |
|
|
— |
|
|
466,823 |
|
|
466,823 |
|
|
— |
|
Management fees |
35,211 |
|
|
5,672 |
|
d, e |
1,475 |
|
|
— |
|
|
42,358 |
|
|
41,724 |
|
|
634 |
|
Incentive income (loss) |
127 |
|
|
40,827 |
|
e |
33 |
|
|
— |
|
|
40,987 |
|
|
40,829 |
|
|
158 |
|
Investment income (loss) |
— |
|
|
18,895 |
|
f |
— |
|
|
— |
|
|
18,895 |
|
|
32,566 |
|
|
(13,671 |
) |
Interest and dividends |
127,547 |
|
|
(127,547 |
) |
c |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Reimbursement from affiliates |
777 |
|
|
(827 |
) |
b |
50 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Reinsurance premiums |
18,943 |
|
|
(18,943 |
) |
g |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Other revenue |
4,709 |
|
|
(4,982 |
) |
g |
(21 |
) |
|
— |
|
|
(294 |
) |
|
(298 |
) |
|
4 |
|
Consolidated Funds revenues |
4,650 |
|
|
— |
|
|
(4,650 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Total revenues |
1,120,384 |
|
|
(73,724 |
) |
|
(3,113 |
) |
|
— |
|
|
1,043,547 |
|
|
1,056,422 |
|
|
(12,875 |
) |
Interest and dividend expense |
125,850 |
|
|
(99,971 |
) |
c |
— |
|
|
(3,394 |
) |
l |
22,485 |
|
|
18,471 |
|
|
4,014 |
|
Total net revenues |
994,534 |
|
|
26,247 |
|
|
(3,113 |
) |
|
3,394 |
|
|
1,021,062 |
|
|
1,037,951 |
|
|
(16,889 |
) |
Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation & benefits |
583,137 |
|
|
1,436 |
|
i |
— |
|
|
— |
|
|
584,573 |
|
|
582,480 |
|
|
2,093 |
|
Fixed non-compensation expense |
— |
|
|
111,880 |
|
e, j |
— |
|
|
(5,152 |
) |
m |
106,728 |
|
|
106,350 |
|
|
378 |
|
Variable non-compensation expense |
— |
|
|
121,864 |
|
j |
— |
|
|
— |
|
|
121,864 |
|
|
121,846 |
|
|
18 |
|
Other non-compensation expense |
286,666 |
|
|
(286,666 |
) |
a, b, d, g, i |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Depreciation & amortization |
17,324 |
|
|
— |
|
|
— |
|
|
(551 |
) |
n |
16,773 |
|
|
16,756 |
|
|
17 |
|
Non-controlling interest |
— |
|
|
5,584 |
|
j |
— |
|
|
— |
|
|
5,584 |
|
|
5,584 |
|
|
— |
|
Consolidated Funds expenses |
4,793 |
|
|
— |
|
|
(4,793 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Total expenses |
891,920 |
|
|
(45,902 |
) |
|
(4,793 |
) |
|
(5,703 |
) |
|
835,522 |
|
|
833,016 |
|
|
2,506 |
|
Other income (loss) |
54,328 |
|
|
(82,006 |
) |
e, f, h |
27,678 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Income taxes expense / (benefit) |
52,589 |
|
|
(342 |
) |
|
— |
|
|
(52,247 |
) |
o |
— |
|
|
— |
|
|
— |
|
Income (loss) attributable to non-controlling interests in
consolidated subsidiaries and investment funds |
(19,843 |
) |
|
(9,515 |
) |
j |
29,358 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Income (loss) attributable to Cowen Inc. |
$ |
124,196 |
|
|
— |
|
|
— |
|
|
61,344 |
|
|
185,540 |
|
|
204,935 |
|
|
(19,395 |
) |
Less: Preferred stock dividends |
5,094 |
|
|
— |
|
|
— |
|
|
— |
|
|
5,094 |
|
|
4,160 |
|
|
934 |
|
Economic Income (Loss)/ Income (loss) attributable to Cowen
Inc. common stockholders |
$ |
119,102 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
61,344 |
|
|
180,446 |
|
|
200,775 |
|
|
(20,329 |
) |
Add back: Depreciation and amortization expense |
|
|
|
|
|
|
|
|
16,773 |
|
|
16,756 |
|
|
17 |
|
Economic Operating Income (Loss) |
|
|
|
|
|
|
|
|
$ |
197,219 |
|
|
$ |
217,531 |
|
|
$ |
(20,312 |
) |
|
Nine Months Ended September 30, 2019 |
|
US GAAP |
|
Reclassifications and Adjustments |
|
Economic Income |
(Dollars amounts in thousands) |
Net income (loss) |
|
Management Reclassifications |
|
Fund Consolidation Reclassifications (k) |
|
Income Statement Adjustments |
|
Total Economic Income/(Loss) |
|
Operating Company |
|
Asset Company |
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment banking |
$ |
272,103 |
|
$ |
(17,729 |
) |
a, b |
$ |
— |
|
|
$ |
— |
|
|
$ |
254,374 |
|
$ |
254,374 |
|
$ |
— |
|
Brokerage |
302,840 |
|
43,255 |
|
c, h |
— |
|
|
— |
|
|
346,095 |
|
346,095 |
|
— |
|
Management fees |
21,480 |
|
8,684 |
|
d, e |
1,640 |
|
|
— |
|
|
31,804 |
|
30,016 |
|
1,788 |
|
Incentive income (loss) |
724 |
|
33,479 |
|
e |
557 |
|
|
— |
|
|
34,760 |
|
33,998 |
|
762 |
|
Investment income (loss) |
— |
|
19,116 |
|
f |
— |
|
|
— |
|
|
19,116 |
|
13,827 |
|
5,289 |
|
Interest and dividends |
129,846 |
|
(129,846 |
) |
c |
— |
|
|
— |
|
|
— |
|
— |
|
— |
|
Reimbursement from affiliates |
780 |
|
(874 |
) |
b |
94 |
|
|
— |
|
|
— |
|
— |
|
— |
|
Reinsurance premiums |
29,068 |
|
(29,068 |
) |
g |
— |
|
|
— |
|
|
— |
|
— |
|
— |
|
Other revenue |
3,228 |
|
2,109 |
|
g |
14 |
|
|
— |
|
|
5,351 |
|
5,295 |
|
56 |
|
Consolidated Funds revenues |
8,239 |
|
— |
|
|
(8,239 |
) |
|
— |
|
|
— |
|
— |
|
— |
|
Total revenues |
768,308 |
|
(70,874 |
) |
|
(5,934 |
) |
|
— |
|
|
691,500 |
|
683,605 |
|
7,895 |
|
Interest expense (Economic Income/(Loss)) / Interest and dividend
expense (US GAAP) |
125,089 |
|
(101,464 |
) |
c |
— |
|
|
(3,208 |
) |
l |
20,417 |
|
16,371 |
|
4,046 |
|
Total net revenues |
643,219 |
|
30,590 |
|
|
(5,934 |
) |
|
3,208 |
|
|
671,083 |
|
667,234 |
|
3,849 |
|
Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation & benefits |
388,611 |
|
2,365 |
|
i |
— |
|
|
— |
|
|
390,976 |
|
386,593 |
|
4,383 |
|
Fixed non-compensation expense |
— |
|
112,038 |
|
e, j |
— |
|
|
(1,664 |
) |
m |
110,374 |
|
107,889 |
|
2,485 |
|
Variable non-compensation expense |
— |
|
113,855 |
|
j |
— |
|
|
— |
|
|
113,855 |
|
113,728 |
|
127 |
|
Other non-compensation expense |
276,054 |
|
(276,054 |
) |
a, b, d, g, i |
— |
|
|
— |
|
|
— |
|
— |
|
— |
|
Depreciation & amortization |
14,990 |
|
(3 |
) |
|
— |
|
|
— |
|
|
14,987 |
|
14,957 |
|
30 |
|
Non-controlling interest |
— |
|
2,944 |
|
j |
— |
|
|
— |
|
|
2,944 |
|
2,944 |
|
— |
|
Goodwill impairment |
4,100 |
|
— |
|
|
— |
|
|
(4,100 |
) |
n |
— |
|
— |
|
— |
|
Consolidated Funds expenses |
6,229 |
|
— |
|
|
(6,229 |
) |
|
— |
|
|
— |
|
— |
|
— |
|
Total expenses |
689,984 |
|
(44,855 |
) |
|
(6,229 |
) |
|
(5,764 |
) |
|
633,136 |
|
626,111 |
|
7,025 |
|
Other income (loss) |
82,976 |
|
(73,907 |
) |
e, f, h |
(9,069 |
) |
|
— |
|
|
— |
|
— |
|
— |
|
Income taxes expense / (benefit) |
9,615 |
|
(48 |
) |
|
— |
|
|
(9,567 |
) |
o |
— |
|
— |
|
— |
|
Income (loss) attributable to non-controlling interests in
consolidated subsidiaries and investment funds |
7,188 |
|
1,586 |
|
j |
(8,774 |
) |
|
— |
|
|
— |
|
— |
|
— |
|
Income (loss) attributable to Cowen Inc. |
19,408 |
|
— |
|
|
— |
|
|
18,539 |
|
|
37,947 |
|
41,123 |
|
(3,176 |
) |
Less: Preferred stock dividends |
5,094 |
|
— |
|
|
— |
|
|
— |
|
|
5,094 |
|
4,058 |
|
1,036 |
|
Economic Income (Loss)/ Income (loss) attributable to Cowen
Inc. common stockholders |
$ |
14,314 |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
18,539 |
|
|
32,853 |
|
37,065 |
|
(4,212 |
) |
Add back: Depreciation and amortization expense |
|
|
|
|
|
|
|
|
14,987 |
|
14,957 |
|
30 |
|
Economic Operating Income (Loss) |
|
|
|
|
|
|
|
|
$ |
47,840 |
|
$ |
52,022 |
|
$ |
(4,182 |
) |
Adjustments made to US GAAP Net Income
(Loss) to arrive at Economic Operating Income (Loss)
Management Reclassifications |
|
Management reclassification adjustments and fund consolidation
reclassification adjustments have no effect on economic income.
These adjustments are reclassifications to change the location of
certain line items. |
a |
Economic Income (Loss) presents underwriting expenses net of
investment banking revenues. |
b |
Economic Income (Loss) presents expenses reimbursed from clients
and affiliates within their respective expense category but is
included as a part of revenues under US GAAP. |
c |
Economic Income (Loss) brokerage revenues included net securities
borrowed and securities loaned activities which are shown gross in
interest income and interest expense for US GAAP. |
d |
Economic Income (Loss) presents revenues net of fund start-up costs
and distribution fees paid to agents. |
e |
Economic Income (Loss) recognizes the Company's proportionate share
of management and incentive fees and associated share of expenses
on a gross basis for certain real estate operating entities, the
healthcare royalty business and the activist business.
Additionally, carried interest, which the Company applies an equity
ownership model to, is recorded in other income (loss) for US GAAP
and is shown as incentive income for Economic Income (Loss). |
f |
Economic Income (Loss) recognizes Company income from proprietary
trading (including interest and dividends) for which the majority
of this activity is shown in other income (loss) for US GAAP
reporting. |
g |
Economic Income (Loss) recognizes underwriting income from the
Company's insurance related activities, net of expenses, within
other revenue. The costs are recorded within expenses for US GAAP
reporting. |
h |
Economic Income (Loss) recognizes gains and losses on investments
held as part of the Company's facilitation and trading business
within brokerage revenues as these investments are directly related
to the markets business activities. |
i |
Economic Income (Loss) presents certain payments to associated
banking partners as compensation rather than non-compensation
expenses. |
j |
Economic Income (Loss) presents US GAAP expenses as either Fixed
non-compensation or Variable non-compensation expenses. The Company
also presents US GAAP Income (loss) attributable to non-controlling
interests within total other expenses for Economic Income
(Loss). |
Fund Consolidation Reclassifications |
k |
The impacts of consolidation and the related elimination entries of
the Consolidated Funds are not included in Economic Income (Loss).
Adjustments to reconcile to US GAAP net income (loss) included
elimination of incentive income and management fees earned from the
Consolidated Funds and addition of investment fund expenses
excluding management fees paid, investment fund revenues and
investment income (loss). |
Income Statement Adjustments |
l |
Economic Income (Loss) excludes the amortization of discount on
convertible debt. |
m |
Economic Income (Loss) excludes acquisition related adjustments as
management does not consider these items when evaluating the
performance of the Company. |
n |
Economic Income (Loss) excludes goodwill and intangible
impairment. |
o |
Economic Income (Loss) excludes income taxes. |
Cowen (NASDAQ:COWN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cowen (NASDAQ:COWN)
Historical Stock Chart
From Apr 2023 to Apr 2024